Related Experiment Video
Updated: Jul 9, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
STK25 Inhibits Epithelial-Mesenchymal Transition and Metastasis via the TGF-β/SMAD2 Signaling Pathway in Colorectal
Pin Gao1, Hao Hao1, Jiangbo Chen1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Cancer Hospital & Institute, Beijing, China.
Summary
Low expression of Serine/threonine protein kinase 25 (STK25) correlates with increased colorectal cancer (CRC) metastasis and poor survival. STK25 inhibits cancer cell migration and epithelial-mesenchymal transition (EMT) via the TGF-β pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastatic colorectal cancer (CRC) significantly impacts patient prognosis.
- The role of Serine/threonine protein kinase 25 (STK25) in cancer progression is not fully understood.
- Previous studies show STK25 involvement in various biological processes, but its function in CRC metastasis is debated.
Purpose of the Study:
- To investigate the role of STK25 in colorectal cancer (CRC) metastasis.
- To elucidate the underlying molecular mechanisms of STK25 in CRC progression.
- To evaluate STK25 as a potential therapeutic target for CRC.
Main Methods:
- Analysis of STK25 expression in CRC patient samples and correlation with survival data.
- In vitro and in vivo functional assays to assess the impact of STK25 knockdown on CRC cell migration and metastasis.
- Investigation of the TGF-β signaling pathway and SMAD2 activation in response to STK25 depletion.
Main Results:
- Low STK25 expression was significantly associated with increased tumor metastasis and poorer survival in CRC patients.
- STK25 knockdown promoted epithelial-mesenchymal transition (EMT) and enhanced metastasis of CRC cells in vitro and in vivo.
- STK25 depletion led to increased migration and EMT progression by activating the TGF-β/SMAD2 signaling pathway.
- The kinase activity of STK25 is essential for its inhibitory effect on TGF-β signaling.
Conclusions:
- STK25 acts as a tumor suppressor in colorectal cancer, inhibiting metastasis.
- STK25 functions by suppressing the TGF-β/SMAD2 signaling pathway, thereby reducing EMT and cell migration.
- STK25 represents a promising therapeutic target for overcoming TGF-β/SMAD2-mediated metastasis in CRC.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:41Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...